Melissa Epperly

Melissa Epperly is a highly accomplished professional with a diverse background in finance, business development, operations, and healthcare. She holds an MBA from Harvard Business School and has a solid educational foundation in Biochemistry and Economics from the University of Virginia. Melissa currently serves as the CFO of Zentalis Pharmaceuticals and has held key financial positions in leading organizations in the pharmaceutical and investment banking sectors. Prior to her role at Zentalis Pharmaceuticals, she was the CFO of PsiOxus Therapeutics Ltd and R-Pharm US, where she also led business development and operations. Melissa's extensive experience includes working as a Portfolio Group member at Anchorage Capital Group, L.L.C., conducting equity research at Goldman Sachs, and providing strategic consulting in pharmaceuticals and private equity at Bain & Company. Her finance expertise was honed through roles at Morgan Stanley, where she focused on investment banking, healthcare, and equity analysis.